Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Baxter has issued an important product information communication to advise customers of the risk of air or gas embolism with the inappropriate use (too high pressure too short distance) of various spray devices used to administer fibrin sealant products such as tisseel and artiss. see also recall number 82143.